Our Team

Greg Collier PhD

Greg Collier PhD

Non-Executive Chair

25+ years biotech experience
Led ChemGenex to $231M acquisition
Chair of Avecho Biotechnology and Tessara Therapeutics

James Campbell PhD MBA

James Campbell PhD MBA

CEO

25+ years biotech experience
Chair of Prescient Therapeutics and AusBiotech
Negotiated and closed >$50M in partnering deals

Sean McGee PhD

Sean McGee PhD

Executive Director and CSO

Professor of Medical Biology, Deakin University
20+ years pioneering MEF2 research
$MM in competitive grants

Andrew Wilks PhD

Andrew Wilks PhD

Non-Executive Director

40+ years cancer research and medicinal chemistry
Founding Partner SYNthesis BioVentures
Multiple successful exits

Dr Tom Gumley

Dr Tom Gumley

Intellectual Property Manager

Biotech patent specialist
20+ years with Australian biotech companies